Skip to content

Chromosome 9 Deletion 9q21 33q22 32 Cn072194

Published: July 22, 2026Updated: August 20, 2026

A rare chromosomal condition where a segment of chromosome 9 is missing, causing developmental delays, intellectual disability, and various health issues. Affected individuals require lifelong, multidisciplinary medical care and early intervention services.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental delay

(neurological)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Microcephaly

(congenital)

Eye abnormalities

(ophthalmologic)

Renal anomalies

(genitourinary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neurodevelopmental and Growth Monitoring

Regular comprehensive monitoring of developmental milestones, growth parameters, and neurological function to identify and address delays associated with 9q21.33q22.32 deletion.

monitoring
3

Ophthalmological and ENT Surgical Interventions

Surgical correction of structural eye abnormalities and hearing impairments commonly associated with 9q21.33q22.32 deletion, including strabismus surgery and cochlear implantation when indicated.

surgical

Additional treatment options

Early Intervention Physical Therapy

Intensive early childhood physical therapy program targeting hypotonia, motor coordination deficits, and developmental motor delays specific to the deletion syndrome.

physical_therapy

Cognitive and Behavioral Intervention Program

Specialized behavioral and cognitive interventions addressing intellectual disability, attention deficits, and autism spectrum features frequently observed in this deletion.

psychological

Symptomatic Pharmacological Management

Medication management for associated symptoms including attention deficit, mood instability, seizure disorders, and other neuropsychiatric manifestations under specialist supervision.

medication

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 9 Deletion 9q21 33q22 32 Cn072194?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2012.

review2012
2

Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015.

guideline2015
3

Tucker T, McGillivray BC, Lewis C, et al. Phenotypic characterization of individuals with 9q21.33-q22.32 microdeletions using high-resolution oligonucleotide array comparative genomic hybridization. Hum Genet. 2013.

clinical_trial2013
4

Dixon-Salazar TJ, Mooney SD. Understanding rare chromosomal deletions: a systematic review of the clinical and molecular spectrum. Orphanet J Rare Dis. 2018.

meta_analysis2018

Medication Comparisons

Compare medications used to treat Chromosome 9 Deletion 9q21 33q22 32 Cn072194. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy